These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 28185291)
21. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. Jerjen R; Nikpour M; Krieg T; Denton CP; Saracino AM J Am Acad Dermatol; 2022 Nov; 87(5):937-954. PubMed ID: 35131402 [TBL] [Abstract][Full Text] [Related]
33. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Cabral-Marques O; Riemekasten G Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493 [TBL] [Abstract][Full Text] [Related]
34. Development of agents for the treatment of systemic sclerosis. Herrick AL Expert Opin Investig Drugs; 2001 Jul; 10(7):1255-64. PubMed ID: 11772249 [TBL] [Abstract][Full Text] [Related]
35. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458 [TBL] [Abstract][Full Text] [Related]
36. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -]. Asano Y Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132 [TBL] [Abstract][Full Text] [Related]
37. Severe gastrointestinal involvement in systemic sclerosis. Plastiras SC; Tzivras M; Vlachoyiannopoulos PG Clin Rheumatol; 2007 Jun; 26(6):1025-6. PubMed ID: 16550300 [TBL] [Abstract][Full Text] [Related]
39. From mechanisms of action to therapeutic application: A review on current therapeutic approaches and future directions in systemic sclerosis. Del Papa N; Zaccara E Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):756-69. PubMed ID: 27107511 [TBL] [Abstract][Full Text] [Related]
40. Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature. Frech TM; Hudson M Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S179-81. PubMed ID: 26339896 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]